- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-19-0005764

About Bioxera Pharma Private Limited
Data last updated:
Bioxera Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Ar-Ex Laboratories Private Limited. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 14 October 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2005PTC156737. Its GSTIN is 27AACCB9951A1ZT (Maharashtra).
The company has an authorised share capital of ₹3.1 Cr and a paid-up capital of ₹76 Lakh. It is led by directors including Satish Narayan Gunjikar (Managing Director) and Ajit Narayan Gunjikar (Managing Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 10 Cama'S Land Mun. Ind Estate Goregaon (E), Mumbai, Maharashtra, India – 400063.
As per the financials filed for FY 2025, the company reported a revenue of ₹79.2 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹14.12 Cr (net margin 17.8%) and EBITDA of ₹21.09 Cr (EBITDA margin 26.6%). Revenue has grown at a compounded annual rate (CAGR) of 8% over five years.
The company has about 84 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Bioxera Pharma. As per MCA filings, the company has open charges of ₹38.23 Cr and satisfied charges of ₹7.03 Cr on record. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹92.5 Lakh; the latest was in March 2019. Its 9 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 4 smaller; the largest is Adroit Pharmachem Private Limited with revenue of ₹83.57 Cr. The company has 4 MSME Form 1 returns on record between 2019 and 2020, listing 37 overdue payments to 13 micro and small suppliers.
Bioxera Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0005764). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bioxerapharma.com.
Company details
Recognitions & Rankings of Bioxera Pharma
Contact details
Bioxera Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is bioxerapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No 10 Cama'S Land Mun. Ind Estate Goregaon (E), Mumbai, Maharashtra, India – 400063
- IndustryPharma, API Manufacturers
To see the full contact details of Bioxera Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Bioxera Pharma operates one associated brand: Bioxera Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and exporting of APIs and intermediates in the pharmaceutical sector. | bioxerapharma.com |
Business activity
The main business activity of Bioxera Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Bioxera Pharma Private Limited, buy the company report.
Financials of Bioxera Pharma Private Limited
FY 2025 filings availableBioxera Pharma Private Limited reported revenue of ₹79.2 Cr (up 24% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 24% growth in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹21.09 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14.12 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 26.6% | ||||
| Net Profit Margin | 17.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bioxera Pharma Private Limited, buy the company report.
Board of directors of Bioxera Pharma Private Limited
Bioxera Pharma has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nitin Bhalchandra Mangaonkar Also directs: Ar-Ex Laboratories Private Limited | Director | 16 Oct 2005 | 21 Years 1 Months | Current |
| Satish Narayan Gunjikar | Managing Director | 14 Oct 2005 | 21 Years 1 Months | Current |
| Ajit Narayan Gunjikar Also directs: Ar-Ex Laboratories Private Limited, Ar-Ex Specialities Private Limited, Bioxera Drugs Private Limited and 2 more | Managing Director | 14 Oct 2005 | 21 Years 1 Months | Current |
| Sudha Narayan Gunjikar Also directs: Ar-Ex Laboratories Private Limited | Whole-Time Director | 16 Oct 2005 | 21 Years 1 Months | Current |
Peer comparison
Bioxera Pharma Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Adroit Pharmachem Private Limited | ₹83.57 Cr (FY 2025) | 34.0% | Vadodara, Gujarat, India | |||
| Biotavia Labs Private Limited | ₹83.55 Cr (FY 2025) | -56.0% | Delhi, India | |||
| SNJ Labs Private Limited | ₹83.01 Cr (FY 2025) | 28.0% | Rajkot, Gujarat, India | |||
| Adeep Life Sciences Private Limited | ₹82.67 Cr (FY 2024) | 87.0% | Hyderabad, Telangana, India | |||
| Abhilash Chemicals and Pharmaceuticals Private Limited | ₹82.45 Cr (FY 2025) | -16.0% | Madurai, Tamil Nadu, India | |||
| Bioxera Pharma Private Limitedthis company | ₹79.2 Cr (FY 2025) | ₹14.12 Cr | 17.8% | 24.0% | 84 | Mumbai, Maharashtra, India |
| Clarion Organics Limited | ₹78.17 Cr (FY 2024) | 14.0% | Bhandara, Maharashtra, India | |||
| Pratap Organics Private Limited | ₹78.04 Cr (FY 2024) | 0.0% | Navi Mumbai, Maharashtra, India | |||
| Asence Pharma Private Limited | ₹77.56 Cr (FY 2025) | 19.0% | Vadodara, Gujarat, India | |||
| J P N Pharma Private Limited | ₹77.5 Cr (FY 2024) | 0.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Bioxera Pharma Private Limited, buy the company report.
Auditor
Bioxera Pharma Private Limited is audited by R. U. Kamath & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R. U. Kamath & Co | FY 2023 | 034431 |
Shareholding
The shareholding of Bioxera Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Bioxera Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Jul 2019 | 100275346 | Others | ₹5.5 Cr | Open | |
| 26 Feb 2018 | 100162756 | Others | ₹1 Cr | Open | |
| 12 Oct 2017 | 100131209 | Others | ₹75 Lakh | Open | |
| 24 Jan 2017 | 100075769 | Others | ₹48 Lakh | Open | |
| 20 Nov 2015 | 10616222 | The Saraswat Co-Op. Bank Limited | ₹60 Lakh | Open |
To see the full charge records of Bioxera Pharma Private Limited, buy the company report.
Total charge records: 16 View all charges
Deals & funding
Bioxera Pharma Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹92.5 Lakh; the latest was in March 2019.
Deals on record (1 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: Ar-Ex Laboratories Private Limited Seller: Ar-Ex Chemicon Private Limited |
To see the full deal history of Bioxera Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Bioxera Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
Credit ratings & regulatory alerts
Bioxera Pharma Private Limited was last rated by Crisil on 26 Nov 2019.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 26 Nov 2019 |
To see the full credit ratings and regulatory alerts of Bioxera Pharma Private Limited, buy the company report.
MSME payment delays
Bioxera Pharma Private Limited has 4 MSME Form 1 returns on record between 2019 and 2020, listing 37 overdue payments to 13 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 13)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Premier Intermediates Limited | |||
| an individual supplier | |||
| Chromatopak Analytical Instrumentation (India) Pvt Ltd | |||
| Sima Products | |||
| Leading Edge Systems Private Limited |
To see the full MSME payment records of Bioxera Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Bioxera Pharma Private Limited has a workforce of 84 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 84 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Bioxera Pharma Private Limited, buy the company report.
GST
Bioxera Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCB9951A1ZT | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Bioxera Pharma Private Limited, buy the company report.
Recent activity
Bioxera Pharma Private Limited has 7 board changes on record since 2005: 4 appointments and 3 cessations. The latest: Ajit Narayan Gunjikar ceased to be Director on 01 Dec 2014.
23 earlier events are in the company report.
Frequently asked questions
Bioxera Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 14 October 2005 (21+ years old) and is registered under CIN U24230MH2005PTC156737.
Bioxera Pharma has 4 current directors:
- Satish Narayan Gunjikar - Managing Director
- Ajit Narayan Gunjikar - Managing Director
- Sudha Narayan Gunjikar - Whole-Time Director
- Nitin Bhalchandra Mangaonkar - Director
The latest financial statements of Bioxera Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Bioxera Pharma is 27AACCB9951A1ZT, registered in Maharashtra.
The CIN (Corporate Identification Number) of Bioxera Pharma is U24230MH2005PTC156737. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bioxera Pharma was incorporated on 14 October 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.
Bioxera Pharma has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹92.5 Lakh; the latest was in March 2019.
The peers of Bioxera Pharma by revenue are Adroit Pharmachem Private Limited, Biotavia Labs Private Limited, SNJ Labs Private Limited, Adeep Life Sciences Private Limited, Abhilash Chemicals and Pharmaceuticals Private Limited and 4 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ajit Narayan Gunjikar ceased to be Director on 01 Dec 2014. Satish Narayan Gunjikar ceased to be Director on 01 Dec 2014. Sudha Narayan Gunjikar ceased to be Director on 01 Dec 2014. Bioxera Pharma has 7 board changes on record in total.
Yes, Bioxera Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0005764).
Bioxera Pharma has 4 MSME Form 1 returns on record between 2019 and 2020, listing 37 overdue payments to 13 micro and small suppliers. The latest return was filed on 03 Nov 2020.
Bioxera Pharma can be reached through the website bioxerapharma.com. Its registered office is in Mumbai, Maharashtra, India.

